Kidney cancer occurs when abnormal cells form within the tiny tubes that filter blood through the kidneys. These cells develop into a tumor that can grow and spread into other areas of the body.Â
The most common type of kidney cancer, accounting for more than 90% of cases, is called renal cell carcinoma (RCC). When RCC is diagnosed in its early stages, the 5-year survival rate is 93%. Â
According to the Louisiana Department of Health, kidney cancer is the 6th most common type of cancer in the state. Louisiana ranks 3rd in the United States for kidney cancer deaths.Â
For more resources, visit marybird.org/resources.
There are no screening recommendations for people at average risk of developing kidney cancer. Most cases are found during imaging tests for unrelated conditions or symptoms.Â
Talk with your doctor to see if a kidney cancer screening is right for you.Â
Most people who are diagnosed with kidney cancer are older adults, typically between the ages of 60-84. Men are more than twice as likely than women to develop kidney cancer. There is a higher incidence of kidney cancer among African American, Native American, and Alaska Native people.Â
Lifestyle habits play a big role in the risk of kidney cancer. Around 15-20% of patients are active smokers when they are diagnosed. You are also at greater risk if you have obesity and/or high blood pressure. Numerous studies have shown there is a significant link between kidney cancer and long-term use of pain relievers such as acetaminophen (Tylenol), ibuprofen (Advil), and naproxen sodium (Aleve).Â
Inherited conditions account for approximately 5-8% of kidney cancer diagnoses. Talk to your doctor about genetic testing and genetic counseling if you have a family history of kidney cancer.Â
Clinical trials are research studies that involve human beings in order to test new ways to prevent, detect, diagnose or treat diseases. A drug must be part of a clinical trial before the FDA will approve it to be put on the market. Oncology clinical trials are conducted in order to test new drugs or a new combination of drug treatments, new surgery and radiation therapies and new medical devices. Every Cancer Center patient is evaluated for participation in a clinical trial. Those who meet the criteria to participate in clinical research receive a standard of care treatment, but with the added benefit of a trial that may enhance their outcomes. Â
If interested in volunteering to participate in a clinical research trial, or if you have concerns about the conduct of clinical research, please contact the Clinical Research office at (225) 215-1353, or by email at clinicalresearch@marybird.com.Â